ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global NK Cells Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-37J7385
Home | Market Reports | Health| Pharmacy
Global NK Cells Market Insights and Forecast to 2028
BUY CHAPTERS

Global NK Cells Market Research Report 2025

Code: QYRE-Auto-37J7385
Report
September 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Chipscreen Biosciences
Affimed NV
Altor Bioscience
Innate Pharma
Takeda
Sorrento Therapeutics
NantKwest Inc
Bristol–Myers Squibb
NKT
Henry Ford Health Services
Fortress Biotech

NK Cells Market

The global market for NK Cells was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Natural killer lymphocytes: NK cells for short, are differentiated from lymphocytes in the bone marrow, accounting for 2% to 5% of the total number of lymphocytes in the blood. NK cells are widely distributed in the human body, in peripheral blood and spleen. , NK cell activity is highest in lymph nodes. NK cells are present in the lamina propria of hollow organ walls and in the interstitium of some solid organs. NK cell activity is lower in bone marrow. NK cells are large lymphocytes with an average diameter of 12~15μm, with more cytoplasm, and many azurophilic granules of different sizes in the cytoplasm, so it is also called large granular lymphocyte (LGL). The nucleus is oval, and under the electron microscope, the cells are The azurophilic granules in the cytoplasm are lysosomes. The chromatin in the nucleus is rich, and heterochromatin is mostly at the edge. There are short microvilli on the cell surface. NK cells do not need antigen activation, let alone the assistance of antibodies. They can Directly killing target cells, such as virus-infected cells and tumor cells, the anti-infection and anti-tumor killing effects of NK cells are broad-spectrum.
North American market for NK Cells is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for NK Cells is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of NK Cells include Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb, NKT, Henry Ford Health Services, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for NK Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NK Cells.
The NK Cells market size, estimations, and forecasts are provided in terms of sales volume (g) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global NK Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NK Cells manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of NK Cells Market Report

Report Metric Details
Report Name NK Cells Market
Segment by Type
  • Mogamulizumab
  • Lorvotuzumab Mertansine
  • Others
Segment by Application
  • Cancer
  • Cardiovascular Diseases
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb, NKT, Henry Ford Health Services, Fortress Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of NK Cells manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of NK Cells in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the NK Cells Market report?

Ans: The main players in the NK Cells Market are Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb, NKT, Henry Ford Health Services, Fortress Biotech

What are the Application segmentation covered in the NK Cells Market report?

Ans: The Applications covered in the NK Cells Market report are Cancer, Cardiovascular Diseases, Others

What are the Type segmentation covered in the NK Cells Market report?

Ans: The Types covered in the NK Cells Market report are Mogamulizumab, Lorvotuzumab Mertansine, Others

1 NK Cells Market Overview
1.1 Product Definition
1.2 NK Cells by Type
1.2.1 Global NK Cells Market Value Comparison by Type (2024 VS 2031)
1.2.2 Mogamulizumab
1.2.3 Lorvotuzumab Mertansine
1.2.4 Others
1.3 NK Cells by Application
1.3.1 Global NK Cells Market Value by Application (2024 VS 2031)
1.3.2 Cancer
1.3.3 Cardiovascular Diseases
1.3.4 Others
1.4 Global NK Cells Market Size Estimates and Forecasts
1.4.1 Global NK Cells Revenue 2020-2031
1.4.2 Global NK Cells Sales 2020-2031
1.4.3 Global NK Cells Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 NK Cells Market Competition by Manufacturers
2.1 Global NK Cells Sales Market Share by Manufacturers (2020-2025)
2.2 Global NK Cells Revenue Market Share by Manufacturers (2020-2025)
2.3 Global NK Cells Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of NK Cells, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of NK Cells, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of NK Cells, Product Type & Application
2.7 Global Key Manufacturers of NK Cells, Date of Enter into This Industry
2.8 Global NK Cells Market Competitive Situation and Trends
2.8.1 Global NK Cells Market Concentration Rate
2.8.2 The Global 5 and 10 Largest NK Cells Players Market Share by Revenue
2.8.3 Global NK Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global NK Cells Market Scenario by Region
3.1 Global NK Cells Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global NK Cells Sales by Region: 2020-2031
3.2.1 Global NK Cells Sales by Region: 2020-2025
3.2.2 Global NK Cells Sales by Region: 2026-2031
3.3 Global NK Cells Revenue by Region: 2020-2031
3.3.1 Global NK Cells Revenue by Region: 2020-2025
3.3.2 Global NK Cells Revenue by Region: 2026-2031
3.4 North America NK Cells Market Facts & Figures by Country
3.4.1 North America NK Cells Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America NK Cells Sales by Country (2020-2031)
3.4.3 North America NK Cells Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe NK Cells Market Facts & Figures by Country
3.5.1 Europe NK Cells Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe NK Cells Sales by Country (2020-2031)
3.5.3 Europe NK Cells Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific NK Cells Market Facts & Figures by Region
3.6.1 Asia Pacific NK Cells Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific NK Cells Sales by Region (2020-2031)
3.6.3 Asia Pacific NK Cells Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America NK Cells Market Facts & Figures by Country
3.7.1 Latin America NK Cells Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America NK Cells Sales by Country (2020-2031)
3.7.3 Latin America NK Cells Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa NK Cells Market Facts & Figures by Country
3.8.1 Middle East and Africa NK Cells Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa NK Cells Sales by Country (2020-2031)
3.8.3 Middle East and Africa NK Cells Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global NK Cells Sales by Type (2020-2031)
4.1.1 Global NK Cells Sales by Type (2020-2025)
4.1.2 Global NK Cells Sales by Type (2026-2031)
4.1.3 Global NK Cells Sales Market Share by Type (2020-2031)
4.2 Global NK Cells Revenue by Type (2020-2031)
4.2.1 Global NK Cells Revenue by Type (2020-2025)
4.2.2 Global NK Cells Revenue by Type (2026-2031)
4.2.3 Global NK Cells Revenue Market Share by Type (2020-2031)
4.3 Global NK Cells Price by Type (2020-2031)
5 Segment by Application
5.1 Global NK Cells Sales by Application (2020-2031)
5.1.1 Global NK Cells Sales by Application (2020-2025)
5.1.2 Global NK Cells Sales by Application (2026-2031)
5.1.3 Global NK Cells Sales Market Share by Application (2020-2031)
5.2 Global NK Cells Revenue by Application (2020-2031)
5.2.1 Global NK Cells Revenue by Application (2020-2025)
5.2.2 Global NK Cells Revenue by Application (2026-2031)
5.2.3 Global NK Cells Revenue Market Share by Application (2020-2031)
5.3 Global NK Cells Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Chipscreen Biosciences
6.1.1 Chipscreen Biosciences Company Information
6.1.2 Chipscreen Biosciences Description and Business Overview
6.1.3 Chipscreen Biosciences NK Cells Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Chipscreen Biosciences NK Cells Product Portfolio
6.1.5 Chipscreen Biosciences Recent Developments/Updates
6.2 Affimed NV
6.2.1 Affimed NV Company Information
6.2.2 Affimed NV Description and Business Overview
6.2.3 Affimed NV NK Cells Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Affimed NV NK Cells Product Portfolio
6.2.5 Affimed NV Recent Developments/Updates
6.3 Altor BioScience
6.3.1 Altor BioScience Company Information
6.3.2 Altor BioScience Description and Business Overview
6.3.3 Altor BioScience NK Cells Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Altor BioScience NK Cells Product Portfolio
6.3.5 Altor BioScience Recent Developments/Updates
6.4 Innate Pharma
6.4.1 Innate Pharma Company Information
6.4.2 Innate Pharma Description and Business Overview
6.4.3 Innate Pharma NK Cells Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Innate Pharma NK Cells Product Portfolio
6.4.5 Innate Pharma Recent Developments/Updates
6.5 Takeda
6.5.1 Takeda Company Information
6.5.2 Takeda Description and Business Overview
6.5.3 Takeda NK Cells Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Takeda NK Cells Product Portfolio
6.5.5 Takeda Recent Developments/Updates
6.6 Sorrento Therapeutics
6.6.1 Sorrento Therapeutics Company Information
6.6.2 Sorrento Therapeutics Description and Business Overview
6.6.3 Sorrento Therapeutics NK Cells Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sorrento Therapeutics NK Cells Product Portfolio
6.6.5 Sorrento Therapeutics Recent Developments/Updates
6.7 NantKwest
6.7.1 NantKwest Company Information
6.7.2 NantKwest Description and Business Overview
6.7.3 NantKwest NK Cells Sales, Revenue and Gross Margin (2020-2025)
6.7.4 NantKwest NK Cells Product Portfolio
6.7.5 NantKwest Recent Developments/Updates
6.8 Bristol-Myers Squibb
6.8.1 Bristol-Myers Squibb Company Information
6.8.2 Bristol-Myers Squibb Description and Business Overview
6.8.3 Bristol-Myers Squibb NK Cells Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bristol-Myers Squibb NK Cells Product Portfolio
6.8.5 Bristol-Myers Squibb Recent Developments/Updates
6.9 NKT
6.9.1 NKT Company Information
6.9.2 NKT Description and Business Overview
6.9.3 NKT NK Cells Sales, Revenue and Gross Margin (2020-2025)
6.9.4 NKT NK Cells Product Portfolio
6.9.5 NKT Recent Developments/Updates
6.10 Henry Ford Health Services
6.10.1 Henry Ford Health Services Company Information
6.10.2 Henry Ford Health Services Description and Business Overview
6.10.3 Henry Ford Health Services NK Cells Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Henry Ford Health Services NK Cells Product Portfolio
6.10.5 Henry Ford Health Services Recent Developments/Updates
6.11 Fortress Biotech
6.11.1 Fortress Biotech Company Information
6.11.2 Fortress Biotech Description and Business Overview
6.11.3 Fortress Biotech NK Cells Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Fortress Biotech NK Cells Product Portfolio
6.11.5 Fortress Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 NK Cells Industry Chain Analysis
7.2 NK Cells Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 NK Cells Production Mode & Process Analysis
7.4 NK Cells Sales and Marketing
7.4.1 NK Cells Sales Channels
7.4.2 NK Cells Distributors
7.5 NK Cells Customer Analysis
8 NK Cells Market Dynamics
8.1 NK Cells Industry Trends
8.2 NK Cells Market Drivers
8.3 NK Cells Market Challenges
8.4 NK Cells Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Chipscreen Biosciences
Affimed NV
Altor Bioscience
Innate Pharma
Takeda
Sorrento Therapeutics
NantKwest Inc
Bristol–Myers Squibb
NKT
Henry Ford Health Services
Fortress Biotech
List of Tables
 Table 1. Global NK Cells Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global NK Cells Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global NK Cells Market Competitive Situation by Manufacturers in 2024
 Table 4. Global NK Cells Sales (g) of Key Manufacturers (2020-2025)
 Table 5. Global NK Cells Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global NK Cells Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global NK Cells Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market NK Cells Average Price (USD/g) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of NK Cells, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of NK Cells, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of NK Cells, Product Type & Application
 Table 12. Global Key Manufacturers of NK Cells, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global NK Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK Cells as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global NK Cells Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global NK Cells Sales by Region (2020-2025) & (g)
 Table 18. Global NK Cells Sales Market Share by Region (2020-2025)
 Table 19. Global NK Cells Sales by Region (2026-2031) & (g)
 Table 20. Global NK Cells Sales Market Share by Region (2026-2031)
 Table 21. Global NK Cells Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global NK Cells Revenue Market Share by Region (2020-2025)
 Table 23. Global NK Cells Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global NK Cells Revenue Market Share by Region (2026-2031)
 Table 25. North America NK Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America NK Cells Sales by Country (2020-2025) & (g)
 Table 27. North America NK Cells Sales by Country (2026-2031) & (g)
 Table 28. North America NK Cells Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America NK Cells Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe NK Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe NK Cells Sales by Country (2020-2025) & (g)
 Table 32. Europe NK Cells Sales by Country (2026-2031) & (g)
 Table 33. Europe NK Cells Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe NK Cells Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific NK Cells Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific NK Cells Sales by Region (2020-2025) & (g)
 Table 37. Asia Pacific NK Cells Sales by Region (2026-2031) & (g)
 Table 38. Asia Pacific NK Cells Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific NK Cells Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America NK Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America NK Cells Sales by Country (2020-2025) & (g)
 Table 42. Latin America NK Cells Sales by Country (2026-2031) & (g)
 Table 43. Latin America NK Cells Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America NK Cells Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa NK Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa NK Cells Sales by Country (2020-2025) & (g)
 Table 47. Middle East and Africa NK Cells Sales by Country (2026-2031) & (g)
 Table 48. Middle East and Africa NK Cells Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa NK Cells Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global NK Cells Sales (g) by Type (2020-2025)
 Table 51. Global NK Cells Sales (g) by Type (2026-2031)
 Table 52. Global NK Cells Sales Market Share by Type (2020-2025)
 Table 53. Global NK Cells Sales Market Share by Type (2026-2031)
 Table 54. Global NK Cells Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global NK Cells Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global NK Cells Revenue Market Share by Type (2020-2025)
 Table 57. Global NK Cells Revenue Market Share by Type (2026-2031)
 Table 58. Global NK Cells Price (USD/g) by Type (2020-2025)
 Table 59. Global NK Cells Price (USD/g) by Type (2026-2031)
 Table 60. Global NK Cells Sales (g) by Application (2020-2025)
 Table 61. Global NK Cells Sales (g) by Application (2026-2031)
 Table 62. Global NK Cells Sales Market Share by Application (2020-2025)
 Table 63. Global NK Cells Sales Market Share by Application (2026-2031)
 Table 64. Global NK Cells Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global NK Cells Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global NK Cells Revenue Market Share by Application (2020-2025)
 Table 67. Global NK Cells Revenue Market Share by Application (2026-2031)
 Table 68. Global NK Cells Price (USD/g) by Application (2020-2025)
 Table 69. Global NK Cells Price (USD/g) by Application (2026-2031)
 Table 70. Chipscreen Biosciences Company Information
 Table 71. Chipscreen Biosciences Description and Business Overview
 Table 72. Chipscreen Biosciences NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 73. Chipscreen Biosciences NK Cells Product
 Table 74. Chipscreen Biosciences Recent Developments/Updates
 Table 75. Affimed NV Company Information
 Table 76. Affimed NV Description and Business Overview
 Table 77. Affimed NV NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 78. Affimed NV NK Cells Product
 Table 79. Affimed NV Recent Developments/Updates
 Table 80. Altor BioScience Company Information
 Table 81. Altor BioScience Description and Business Overview
 Table 82. Altor BioScience NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 83. Altor BioScience NK Cells Product
 Table 84. Altor BioScience Recent Developments/Updates
 Table 85. Innate Pharma Company Information
 Table 86. Innate Pharma Description and Business Overview
 Table 87. Innate Pharma NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 88. Innate Pharma NK Cells Product
 Table 89. Innate Pharma Recent Developments/Updates
 Table 90. Takeda Company Information
 Table 91. Takeda Description and Business Overview
 Table 92. Takeda NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 93. Takeda NK Cells Product
 Table 94. Takeda Recent Developments/Updates
 Table 95. Sorrento Therapeutics Company Information
 Table 96. Sorrento Therapeutics Description and Business Overview
 Table 97. Sorrento Therapeutics NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 98. Sorrento Therapeutics NK Cells Product
 Table 99. Sorrento Therapeutics Recent Developments/Updates
 Table 100. NantKwest Company Information
 Table 101. NantKwest Description and Business Overview
 Table 102. NantKwest NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 103. NantKwest NK Cells Product
 Table 104. NantKwest Recent Developments/Updates
 Table 105. Bristol-Myers Squibb Company Information
 Table 106. Bristol-Myers Squibb Description and Business Overview
 Table 107. Bristol-Myers Squibb NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 108. Bristol-Myers Squibb NK Cells Product
 Table 109. Bristol-Myers Squibb Recent Developments/Updates
 Table 110. NKT Company Information
 Table 111. NKT Description and Business Overview
 Table 112. NKT NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 113. NKT NK Cells Product
 Table 114. NKT Recent Developments/Updates
 Table 115. Henry Ford Health Services Company Information
 Table 116. Henry Ford Health Services Description and Business Overview
 Table 117. Henry Ford Health Services NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 118. Henry Ford Health Services NK Cells Product
 Table 119. Henry Ford Health Services Recent Developments/Updates
 Table 120. Fortress Biotech Company Information
 Table 121. Fortress Biotech Description and Business Overview
 Table 122. Fortress Biotech NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 123. Fortress Biotech NK Cells Product
 Table 124. Fortress Biotech Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. NK Cells Distributors List
 Table 128. NK Cells Customers List
 Table 129. NK Cells Market Trends
 Table 130. NK Cells Market Drivers
 Table 131. NK Cells Market Challenges
 Table 132. NK Cells Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of NK Cells
 Figure 2. Global NK Cells Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global NK Cells Market Share by Type: 2024 & 2031
 Figure 4. Mogamulizumab Product Picture
 Figure 5. Lorvotuzumab Mertansine Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global NK Cells Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global NK Cells Market Share by Application: 2024 & 2031
 Figure 9. Cancer
 Figure 10. Cardiovascular Diseases
 Figure 11. Others
 Figure 12. Global NK Cells Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global NK Cells Market Size (2020-2031) & (US$ Million)
 Figure 14. Global NK Cells Sales (2020-2031) & (g)
 Figure 15. Global NK Cells Average Price (USD/g) & (2020-2031)
 Figure 16. NK Cells Report Years Considered
 Figure 17. NK Cells Sales Share by Manufacturers in 2024
 Figure 18. Global NK Cells Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest NK Cells Players: Market Share by Revenue in NK Cells in 2024
 Figure 20. NK Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global NK Cells Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America NK Cells Sales Market Share by Country (2020-2031)
 Figure 23. North America NK Cells Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. NK Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada NK Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe NK Cells Sales Market Share by Country (2020-2031)
 Figure 27. Europe NK Cells Revenue Market Share by Country (2020-2031)
 Figure 28. Germany NK Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France NK Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. NK Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy NK Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia NK Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific NK Cells Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific NK Cells Revenue Market Share by Region (2020-2031)
 Figure 35. China NK Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan NK Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea NK Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India NK Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia NK Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan NK Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia NK Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand NK Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia NK Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines NK Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America NK Cells Sales Market Share by Country (2020-2031)
 Figure 46. Latin America NK Cells Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico NK Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil NK Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina NK Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa NK Cells Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa NK Cells Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey NK Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia NK Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E NK Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of NK Cells by Type (2020-2031)
 Figure 56. Global Revenue Market Share of NK Cells by Type (2020-2031)
 Figure 57. Global NK Cells Price (USD/g) by Type (2020-2031)
 Figure 58. Global Sales Market Share of NK Cells by Application (2020-2031)
 Figure 59. Global Revenue Market Share of NK Cells by Application (2020-2031)
 Figure 60. Global NK Cells Price (USD/g) by Application (2020-2031)
 Figure 61. NK Cells Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global K Cells Market Research Report 2024
Global Natural Killer Cell Therapeutics Market Research Report 2024
Natural Killer NK Cell Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global NK Cell Cytotoxicity Assay Service Market Research Report 2025
Global Human NK Cell Isolation Kit Market Research Report 2024
Global NK Cell Isolation Kit Market Research Report 2025
Global Natural Killer Cell Therapy Market Insights Forecast to 2030
Global NK Cell Therapy Market Insights Forecast to 2030
Global Natural Killer Cells Therapeutics Market Insights Forecast to 2030
Global Animal PBMC Isolation Kit Market Research Report 2024
Global Natural Killer NK Cell Induction and Culture Kit Market Research Report 2025
Global Human Peripheral Blood Lymphocyte Separation Medium Market Research Report 2024
Global NK Cell Expansion Kit Market Research Report 2025
Global Peripheral Blood Lymphocyte Separation Medium Market Research Report 2024
Global Serum Free NK Cell Culture Kit Market Research Report 2024
Global The Human NK Cell Cytotoxicity Assay Kit Market Research Report 2025
Lymphoma Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Dendritic Cell Cancer Vaccine Immunotherapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Dendritic Cell Cancer Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cytotoxic T Cells CTL Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions